AlphaQuest’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,657
Closed -$168K 690
2025
Q4
$168K Buy
1,657
+759
+85% +$61K 0.01% 1526
2025
Q3
$49.1K Sell
898
-7,641
-89% -$382K ﹤0.01% 1943
2025
Q2
$454K Sell
8,539
-1,364
-14% -$69.3K 0.04% 646
2025
Q1
$429K Buy
9,903
+8,986
+980% +$455K 0.05% 586
2024
Q4
$51.5K Buy
917
+913
+22,825% +$56.8K 0.01% 1284
2024
Q3
$272 Sell
4
-2,233
-100% -$126K ﹤0.01% 1790
2024
Q2
$94.5K Buy
2,237
+2,015
+908% +$111K 0.01% 937
2024
Q1
$15.3K Sell
222
-671
-75% -$42.4K ﹤0.01% 1052
2023
Q4
$66.1K Buy
+893
New +$58.5K 0.01% 842

Other funds holding EXAS

AlphaQuest's EXAS Position: Q1 2026 in Review

AlphaQuest sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,657 shares — an estimated $168K sold.

AlphaQuest first reported a position in EXAS in Q4 2023 and held it in 9 quarters. The position peaked at $454K in Q2 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • AlphaQuest reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 1,657 Exact Sciences shares in Q1 2026, an estimated $168K.
  • AlphaQuest first reported a position in Exact Sciences in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Exact Sciences position peaked at $454K in Q2 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.